Cardiac therapies for Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is a devastating disease that results in life-limiting complications such as loss of skeletal muscle function as well as respiratory and cardiac complications. Advanced therapeutics in pulmonary care have significantly reduced respiratory complication–related mortal...
Main Authors: | Md Nur Ahad Shah, Toshifumi Yokota |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-07-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/17562864231182934 |
Similar Items
-
Recent Trends in Antisense Therapies for Duchenne Muscular Dystrophy
by: Harry Wilton-Clark, et al.
Published: (2023-02-01) -
CRISPR Therapeutics for Duchenne Muscular Dystrophy
by: Esra Erkut, et al.
Published: (2022-02-01) -
Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy
by: Kenji Rowel Q. Lim, et al.
Published: (2018-11-01) -
Eteplirsen in the treatment of Duchenne muscular dystrophy
by: Lim KRQ, et al.
Published: (2017-02-01) -
Antisense and Gene Therapy Options for Duchenne Muscular Dystrophy Arising from Mutations in the N-Terminal Hotspot
by: Harry Wilton-Clark, et al.
Published: (2022-01-01)